Our data showed that PIK3IP1, the suppressor of PI3K/AKT/mTOR signaling, is significantly downregulated in AML cells and that PIK3IP is significantly elevated upon the combination of DZNeP with Ven. The gene discussed is PIK3IP1; the disease is acute myeloid leukemia.